Fluicell AB Total Liabilities

Latest as of March 2026: Skr6.56 Million SEK ≈ $705.64K USD

Fluicell AB total liabilities. Based on the latest financial reports, Fluicell AB (FLUI) has total liabilities worth Skr6.56 Million SEK (≈ $705.64K USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check FLUI asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Fluicell AB (2014–2025)

Total liabilities of Fluicell AB from 2014 to 2025. This chart illustrates how Fluicell AB's total liabilities have evolved over time, based on quarterly financial data.

Fluicell AB Competitors by Total Liabilities

The table below lists competitors of Fluicell AB ranked by their total liabilities.

Company	Country	Total Liabilities
Inspire Veterinary Partners, Inc. NASDAQ:IVP	USA	$19.79 Million
ModivCare Inc NASDAQ:MODV	USA	$1.76 Billion
REY Resources Ltd AU:REY	Australia	AU$21.69 Million
Adneo Ltd AU:AD1	Australia	AU$16.62 Million
Euro Menkul Kiymet Yatirim Ortakligi AS IS:EUYO	Turkey	TL5.13 Million
Pragma Inkaso S.A. WAR:PRI	Poland	zł12.10 Million
Largo SAS PA:ALLGO	France	€14.88 Million
Revelation Biosciences Inc NASDAQ:REVB	USA	$2.43 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Fluicell AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see FLUI total asset value.

Liquidity & Leverage Metrics

Fluicell AB Total Liabilities Ratios Explained

Fluicell AB total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.33	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.46	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.32	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Fluicell AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Fluicell AB (2014–2025)

The table below shows the annual total liabilities of Fluicell AB from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr7.57 Million ≈ $815.08K	+20.72%
2024-12-31	Skr6.27 Million ≈ $675.18K	-29.62%
2023-12-31	Skr8.91 Million ≈ $959.40K	+7.15%
2022-12-31	Skr8.32 Million ≈ $895.36K	+5.72%
2021-12-31	Skr7.87 Million ≈ $846.94K	+47.60%
2020-12-31	Skr5.33 Million ≈ $573.81K	-45.10%
2019-12-31	Skr9.71 Million ≈ $1.05 Million	+273.54%
2018-12-31	Skr2.60 Million ≈ $279.80K	+33.13%
2017-12-31	Skr1.95 Million ≈ $210.17K	+109.10%
2016-12-31	Skr934.00K ≈ $100.51K	-7.71%
2015-12-31	Skr1.01 Million ≈ $108.91K	+108.76%
2014-12-31	Skr484.76K ≈ $52.17K	--

About Fluicell AB

ST:FLUI Sweden Biotechnology

Market Cap

$4.04 Million

Skr37.50 Million SEK

Market Cap Rank

#28939 Global

#643 in Sweden

Share Price

Skr27.30

Change (1 day)

+4.20%

52-Week Range

Skr7.95 - Skr57.20

All Time High

Skr188.78